To “Gultekin et al.,” 21% of ameloblastomas harbored multiple genetic alterations, such as KRAS, PTEN, FGFR2, and PIK3CA, while single NRAS, HRAS, and EGFR mutations occurred only in 5% of BRAF wild-type cases. The gene discussed is HRAS; the disease is ameloblastoma.